| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Regenxbio Inc. (RGNX) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 33 sells. RGNX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 495.9K | $4.50M | - | |
| CEO | 342.5K | $3.11M | - | |
| Other | 247.9K | $2.25M | - | |
| Other | 215.4K | $1.95M | - | |
| Other | 82.2K | $745.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 3, 2018 | Mills Kenneth T.81 | President And CEO | Sell | 20,000 | $60.40 | $1,208,087.00 | -4.1% | |
| Nov 29, 2018 | Beshar Luke M | Director | Sale+OE | 12,784 | $65.00 | $830,960.00 | -100% | |
| Nov 27, 2018 | Beshar Luke M | Director | Sale+OE | 20,507 | $65.03 | $1,333,518.58 | -100% | |
| Nov 26, 2018 | Mills Kenneth T.81 | President And CEO | Sell | 20,000 | $64.17 | $1,283,354.60 | -3.8% | |
| Nov 21, 2018 | Mills Kenneth T.81 | President And CEO | Sell | 15,000 | $61.44 | $921,659.60 | -1.8% | |
| Nov 20, 2018 | Beshar Luke M | Director | Sale+OE | 33,292 | $60.44 | $2,012,209.04 | -94.9% | |
| Nov 19, 2018 | Yoo Stephen | Chief Medical Officer | Sale+OE | 20,414 | $59.53 | $1,215,344.25 | -32.6% | |
| Nov 16, 2018 | Simpson Curran66 | SVP, Technical Operations | Sale+OE | 32,882 | $63.76 | $2,096,418.51 | -12.8% | |
| Nov 15, 2018 | Vasista Vittal79 | Chief Financial Officer | Sell | 7,500 | $60.29 | $452,206.06 | -0.9% | |
| Nov 12, 2018 | Mills Kenneth T.81 | President And CEO | Sell | 20,000 | $63.11 | $1,262,261.20 | -2.3% |